Do you want to read an article? Please log in or register.
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration
Macular Diseases
Related content
Macular Diseases
Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
Ophthalmology.
Gune S, Abdelfattah NS, Karamat A, Balasubramanian S, Marion KM, Morgenthien E, Sadda SR
doi: 10.1016/j.ophtha.2019.09.030.
Macular Diseases
OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study
Ophthalmology.
Nassisi M, Lei J, Abdelfattah NS, Karamat A, Balasubramanian S, Fan W, Uji A, Marion KM, Baker K, Huang X, Morgenthien E, Sadda SR
doi: 10.1016/j.ophtha.2019.05.016.
Macular DiseasesRetinal Diseases
Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
Ophthalmology.
Sadda SR, Tuomi LL, Ding B, Fung AE, Hopkins JJ
doi: 10.1016/j.ophtha.2017.12.026.
RECOMMENDED
Macular Diseases
Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40
★ 3
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
doi: 10.1016/j.ophtha.2019.11.016.
Macular Diseases
Prognostic Value of Retinal Layers in Comparison with Other Risk Factors for Conversion of Intermediate Age-related Macular Degeneration
Ophthalmol Retina.
Thiele S, Nadal J, Pfau M, Saßmannshausen M, Emde LV, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg S, Molecular Diagnostic of Age-related Macular Degeneration Study Group.
doi: 10.1016/j.oret.2019.08.003.
COMMENTED
Macular Diseases
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
★ 3
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1016/j.ophtha.2019.11.004.
Macular Diseases
Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial
Ophthalmology.
Bailey C, Scott LJ, Rogers CA, Reeves BC, Hamill B, Peto T, Chakravarthy U, Harding SP, writing committee for the IVAN Study Group
doi: 10.1016/j.ophtha.
RECOMMENDED
Surgery and InterventionCataracts
Cataract Surgery and the Risk of Developing Late Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 Report Number 27
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
Ophthalmology
Bhandari S, Vitale S, Agrón E, Clemons TE, Chew EY, AREDS2 Research Group.
doi: 10.1016/j.ophtha.2021.11.014
Macular Diseases
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial
JAMA Ophthalmol.
Ramakrishnan MS, Yu Y, VanderBeek BL
doi: 10.1001/jamaophthalmol.2019.4577.